1
|
Park Y, Park S, Lee M. Effectiveness of artificial intelligence in detecting and managing depressive disorders: Systematic review. J Affect Disord 2024; 361:445-456. [PMID: 38889858 DOI: 10.1016/j.jad.2024.06.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/27/2023] [Revised: 11/27/2023] [Accepted: 06/14/2024] [Indexed: 06/20/2024]
Abstract
OBJECTIVES This study underscores the importance of exploring AI's creative applications in treating depressive disorders to revolutionize mental health care. Through innovative integration of AI technologies, the research confirms their positive effects on preventing, diagnosing, and treating depression. The systematic review establishes an evidence base for AI in depression management, offering directions for effective interventions. METHODS This systematic literature review investigates the effectiveness of AI in depression management by analyzing studies from January 1, 2017, to May 31, 2022. Utilizing search engines like IEEE Xplore, PubMed, and Web of Science, the review focused on keywords such as Depression/Mental Health, Machine Learning/Artificial Intelligence, and Prediction/Diagnosis. The analysis of 95 documents involved classification based on use, data type, and algorithm type. RESULTS The study revealed that AI in depression management excelled in accuracy, particularly in monitoring and prediction. Biomarker-derived data demonstrated the highest accuracy, with the CNN algorithm proving most effective. The findings affirm the therapeutic benefits of AI, including treatment, detection, and disease prediction, highlighting its potential in analyzing monitored data for depression management. LIMITATIONS This study exclusively examined the application of AI in individuals with depressive disorders. Interpretation should be cautious due to the limited scope of subjects to this specific population. CONCLUSIONS To introduce digital healthcare and therapies for ongoing depression management, it's crucial to present empirical evidence on the medical fee payment system, safety, and efficacy. These findings support enhanced medical accessibility through digital healthcare, offering personalized disease management for patients seeking non-face-to-face treatment.
Collapse
Affiliation(s)
- Yoonseo Park
- Department of Convergence Healthcare Medicine, Ajou University, Suwon, South Korea.
| | - Sewon Park
- Department of Medical Science, Ajou University School of Medicine, Suwon, South Korea.
| | - Munjae Lee
- Department of Medical Science, Ajou University School of Medicine, Suwon, South Korea.
| |
Collapse
|
2
|
Tong X, Xie H, Wu W, Keller CJ, Fonzo GA, Chidharom M, Carlisle NB, Etkin A, Zhang Y. Individual deviations from normative electroencephalographic connectivity predict antidepressant response. J Affect Disord 2024; 351:220-230. [PMID: 38281595 PMCID: PMC10923099 DOI: 10.1016/j.jad.2024.01.177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/23/2023] [Revised: 01/15/2024] [Accepted: 01/18/2024] [Indexed: 01/30/2024]
Abstract
BACKGROUND Antidepressant medications yield unsatisfactory treatment outcomes in patients with major depressive disorder (MDD) with modest advantages over the placebo, partly due to the elusive mechanisms of antidepressant responses and unexplained heterogeneity in patient's response to treatment. Here we develop a novel normative modeling framework to quantify individual deviations in psychopathological dimensions that offers a promising avenue for the personalized treatment for psychiatric disorders. METHODS We built a normative model with resting-state electroencephalography (EEG) connectivity data from healthy controls of three independent cohorts. We characterized the individual deviation of MDD patients from the healthy norms, based on which we trained sparse predictive models for treatment responses of MDD patients (102 sertraline-medicated and 119 placebo-medicated). Hamilton depression rating scale (HAMD-17) was assessed at both baseline and after the eight-week antidepressant treatment. RESULTS We successfully predicted treatment outcomes for patients receiving sertraline (r = 0.43, p < 0.001) and placebo (r = 0.33, p < 0.001). We also showed that the normative modeling framework successfully distinguished subclinical and diagnostic variabilities among subjects. From the predictive models, we identified key connectivity signatures in resting-state EEG for antidepressant treatment, suggesting differences in neural circuit involvement between sertraline and placebo responses. CONCLUSIONS Our findings and highly generalizable framework advance the neurobiological understanding in the potential pathways of antidepressant responses, enabling more targeted and effective personalized MDD treatment. TRIAL REGISTRATION Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression (EMBARC), NCT#01407094.
Collapse
Affiliation(s)
- Xiaoyu Tong
- Department of Bioengineering, Lehigh University, Bethlehem, PA, USA
| | - Hua Xie
- Center for Neuroscience Research, Children's National Hospital, Washington, DC, USA; George Washington University School of Medicine, Washington, DC, USA
| | - Wei Wu
- Alto Neuroscience, Inc., Los Altos, CA, USA
| | - Corey J Keller
- Department of Psychiatry and Behavioral Sciences, Stanford University, CA, USA; Veterans Affairs Palo Alto Healthcare System, Sierra Pacific Mental Illness, Research, Education, and Clinical Center (MIRECC), Palo Alto, CA, USA
| | - Gregory A Fonzo
- Center for Psychedelic Research and Therapy, Department of Psychiatry and Behavioral Sciences, Dell Medical School, The University of Texas at Austin, TX, USA
| | | | | | - Amit Etkin
- Alto Neuroscience, Inc., Los Altos, CA, USA
| | - Yu Zhang
- Department of Bioengineering, Lehigh University, Bethlehem, PA, USA; Department of Electrical and Computer Engineering, Lehigh University, Bethlehem, PA, USA.
| |
Collapse
|
3
|
Simmatis L, Russo EE, Geraci J, Harmsen IE, Samuel N. Technical and clinical considerations for electroencephalography-based biomarkers for major depressive disorder. NPJ MENTAL HEALTH RESEARCH 2023; 2:18. [PMID: 38609518 PMCID: PMC10955915 DOI: 10.1038/s44184-023-00038-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/05/2023] [Accepted: 09/21/2023] [Indexed: 04/14/2024]
Abstract
Major depressive disorder (MDD) is a prevalent and debilitating psychiatric disease that leads to substantial loss of quality of life. There has been little progress in developing new MDD therapeutics due to a poor understanding of disease heterogeneity and individuals' responses to treatments. Electroencephalography (EEG) is poised to improve this, owing to the ease of large-scale data collection and the advancement of computational methods to address artifacts. This review summarizes the viability of EEG for developing brain-based biomarkers in MDD. We examine the properties of well-established EEG preprocessing pipelines and consider factors leading to the discovery of sensitive and reliable biomarkers.
Collapse
Affiliation(s)
- Leif Simmatis
- Faculty of Medicine, University of Toronto, Toronto, ON, Canada
- Cove Neurosciences Inc., Toronto, ON, Canada
| | - Emma E Russo
- Faculty of Medicine, University of Toronto, Toronto, ON, Canada
- Cove Neurosciences Inc., Toronto, ON, Canada
| | - Joseph Geraci
- Cove Neurosciences Inc., Toronto, ON, Canada
- Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada
| | - Irene E Harmsen
- Faculty of Medicine, University of Toronto, Toronto, ON, Canada
- Cove Neurosciences Inc., Toronto, ON, Canada
| | - Nardin Samuel
- Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
- Cove Neurosciences Inc., Toronto, ON, Canada.
| |
Collapse
|
4
|
Yi L, Xie G, Li Z, Li X, Zhang Y, Wu K, Shao G, Lv B, Jing H, Zhang C, Liang W, Sun J, Hao Z, Liang J. Automatic depression diagnosis through hybrid EEG and near-infrared spectroscopy features using support vector machine. Front Neurosci 2023; 17:1205931. [PMID: 37694121 PMCID: PMC10483285 DOI: 10.3389/fnins.2023.1205931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Accepted: 08/10/2023] [Indexed: 09/12/2023] Open
Abstract
Depression is a common mental disorder that seriously affects patients' social function and daily life. Its accurate diagnosis remains a big challenge in depression treatment. In this study, we used electroencephalography (EEG) and functional near-infrared spectroscopy (fNIRS) and measured the whole brain EEG signals and forehead hemodynamic signals from 25 depression patients and 30 healthy subjects during the resting state. On one hand, we explored the EEG brain functional network properties, and found that the clustering coefficient and local efficiency of the delta and theta bands in patients were significantly higher than those in normal subjects. On the other hand, we extracted brain network properties, asymmetry, and brain oxygen entropy as alternative features, used a data-driven automated method to select features, and established a support vector machine model for automatic depression classification. The results showed the classification accuracy was 81.8% when using EEG features alone and increased to 92.7% when using hybrid EEG and fNIRS features. The brain network local efficiency in the delta band, hemispheric asymmetry in the theta band and brain oxygen sample entropy features differed significantly between the two groups (p < 0.05) and showed high depression distinguishing ability indicating that they may be effective biological markers for identifying depression. EEG, fNIRS and machine learning constitute an effective method for classifying depression at the individual level.
Collapse
Affiliation(s)
- Li Yi
- School of Mechatronic Engineering and Automation, Foshan University, Foshan, China
| | - Guojun Xie
- Department of Psychiatry, The Third People’s Hospital of Foshan, Foshan, China
- Department of Psychiatry, The Third Affiliated Hospital of Foshan University, Foshan, China
| | - Zhihao Li
- School of Medicine, Foshan University, Foshan, China
| | - Xiaoling Li
- Department of Psychiatry, The Third People’s Hospital of Foshan, Foshan, China
- Department of Psychiatry, The Third Affiliated Hospital of Foshan University, Foshan, China
| | - Yizheng Zhang
- School of Mechatronic Engineering and Automation, Foshan University, Foshan, China
| | - Kai Wu
- School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou, China
| | - Guangjian Shao
- School of Mechatronic Engineering and Automation, Foshan University, Foshan, China
| | - Biliang Lv
- School of Medicine, Foshan University, Foshan, China
| | - Huan Jing
- Department of Psychiatry, The Third People’s Hospital of Foshan, Foshan, China
- Department of Psychiatry, The Third Affiliated Hospital of Foshan University, Foshan, China
| | - Chunguo Zhang
- Department of Psychiatry, The Third People’s Hospital of Foshan, Foshan, China
- Department of Psychiatry, The Third Affiliated Hospital of Foshan University, Foshan, China
| | - Wenting Liang
- Department of Psychiatry, The Third People’s Hospital of Foshan, Foshan, China
- Department of Psychiatry, The Third Affiliated Hospital of Foshan University, Foshan, China
| | - Jinyan Sun
- School of Medicine, Foshan University, Foshan, China
| | - Zhifeng Hao
- College of Science, Shantou University, Shantou, China
| | - Jiaquan Liang
- Department of Psychiatry, The Third People’s Hospital of Foshan, Foshan, China
- Department of Psychiatry, The Third Affiliated Hospital of Foshan University, Foshan, China
| |
Collapse
|